Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist

Rothman Institute Orthopaedics

Status and phase

Unknown

Phase 4

Conditions

Satisfaction

Pain, Postoperative

Treatments

Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03864588

2018LonnerSS

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of two methods of administering an adductor canal block (ACB) following total knee arthroplasty (TKA); intraoperative surgeon performed intra-articular adductor canal block (IACB) and anesthesiologist ultrasound guided ADC in the post-anesthesia recovery unit (PACU).

Enrollment

164 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients undergoing unilateral primary TKA with underlying diagnosis of osteoarthritis
ASA I - III
Spinal anesthesia
All patients will have cemented total knee utilizing a medial parapatellar approach with posterior stabilized or cruciate retaining implants. A tourniquet will be used in all cases.
Patients must be between 18 and 80 years of age.
Active and valid email address for the participant.

Exclusion criteria

Allergy to anesthetics or study analgesic medications.
Contraindication to regional anesthesia
Non-english speaking
ASA IV or greater
Renal insufficiency with Cr > 2.0 or hepatic failure
General or epidural anesthesia
Sensory/motor disorder involving the operative limb
Patients who consume preoperative opioids for pain control.
Pregnant women
Mentally disabled patients and patients with psychiatric disorders that would prevent them from properly understanding and evaluating an informed consent process.
Prisoners